Barletta A, Marzullo F, Pellecchia A, Montemurro S, Labriola A, Lomonaco R, Grammatica L, Paradiso A
Clinical and Experimental Oncology Laboratory, Oncology Institute, Bari, Italy.
Anticancer Res. 1998 May-Jun;18(3A):1677-82.
The cancerogenic process of colorectal cancer depends on a series of events involving oncogenes and inactivation of suppressor genes. This study concerns changes in DNA content, p53 and PCNA expression in human colon in dysplastic, precancerous and cancerous tissues.
These characteristics were analyzed in a series of hyperplastic polyps (HP), adenomas (AD), adenocarcinomas evolved within adenomas (AC-AD) and adenocarcinomas (AC) of the large bowel. DNA ploidy was analyzed by flow cytometry and PCNA and p53 expression was evaluated by immunohistochemistry using monoclonal antibodies PC10 and PAb 1801.
Aneuploidy was found in 43/67 (64%) of AC and only occasionally in other subgroups (AC vs all other groups: 64% vs 99%; p = 0.00002). PCNA positivity gradually increased in the sequence from HP to AC and were significantly higher in AC compared to HP (90% vs 44%; p = 0.00007). p53 positive cells were found in 67% of AC while only occasionally in other groups (HP vs AC: p = 0.0002, AD (low dysplasia) vs AC: p = 0.001; AD (moderate dysplasia) vs AC: p = 0.001).
These results demonstrated a progressive immunoreactivity for PCNA in the HP to AC sequence, while p53 positivity and aneuploidy seemed specific for colon carcinoma.
结直肠癌的致癌过程取决于一系列涉及癌基因和抑癌基因失活的事件。本研究关注发育异常、癌前和癌组织中人类结肠DNA含量、p53和PCNA表达的变化。
对一系列大肠的增生性息肉(HP)、腺瘤(AD)、腺瘤内发生的腺癌(AC-AD)和腺癌(AC)进行了这些特征分析。通过流式细胞术分析DNA倍体,并使用单克隆抗体PC10和PAb 1801通过免疫组织化学评估PCNA和p53表达。
在43/67(64%)的AC中发现非整倍体,而在其他亚组中仅偶尔发现(AC与所有其他组:64%对99%;p = 0.00002)。PCNA阳性率从HP到AC逐渐增加,AC中的PCNA阳性率显著高于HP(90%对44%;p = 0.00007)。在67%的AC中发现p53阳性细胞,而在其他组中仅偶尔发现(HP与AC:p = 0.0002,AD(低发育异常)与AC:p = 0.001;AD(中度发育异常)与AC:p = 0.001)。
这些结果表明,在HP到AC序列中PCNA的免疫反应性逐渐增强,而p53阳性和非整倍体似乎是结肠癌特有的。